Inventor
Giovanni Mogna
Inventor
Novara, IT
Overview
Patents· 27 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes22%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for12%
C12NMicroorganisms or enzymes11%
C12RIndexing scheme associated with subclasses c12c - c12q, relating to microorganisms9%
A23VIndexing scheme relating to foods, foodstuffs or non-alcoholic beverages and lactic or propionic acid bacteria used in foodstuffs or food preparation8%
Y02ATechnologies for adaptation to climate change5%
A23Y3%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture2%
A23CDairy products, e.g. milk, butter or cheese1%
PatentTitleYear
11,130,938Compositions comprising live probiotic bacterial cultures of 202111,110,136Composition comprising lactic acid bacteria for use in the preventive and/or curative treatment of recurrent cystitis202111,110,135Bacterial strains belonging to the genus 202111,096,975Compositions for use in the treatment of tumors resistant to chemotherapy202111,077,153Composition for use in treating or preventing viral or bacterial infections in a subject undergoing anti-tumor chemotherapy, leukemia treatment or aids therapy comprising 202111,026,922Compositions comprising melatonin and flavonoids for use in the treatment of tumours resistant to chemotherapy202111,000,557Composition comprising lactic acid bacteria for use in the preventive and/or curative treatment of recurrent cystitis202110,982,184Bacterial strains capable of metabolizing oxalates202110,933,105Composition for use as a support therapy for treatment of tumours, AIDS and leukaemia202110,927,340Bacterial strains capable of metabolizing oxalates202110,738,274Multilayer microencapsulated probiotic bacteria202010,688,138Conjugated linoleic acid-producing strains of probiotic bacteria and use thereof for the preparation of a food, dietetic or pharmaceutical composition202010,428,395Method for the preparation of anallergic probiotic bacterial cultures and related use201910,413,576Therapy for use in the treatment of tumors, acquired immunodeficiency syndrome and leukemias by dual immune biostimulation201910,384,847Material impermeable to humidity and oxygen for packaging dietary products, cosmetics and medicinal specialities201910,286,017Probiotic bacterial strains and symbiotic composition containing the same intended for infant food201910,028,982Composition comprising N-acetylcysteine and/or microencapsulated gastroprotected lysozyme in association with probiotic bacteria capable of restoring the stomach's own barrier effect which is lost during the pharmacological treatment of gastric hyperacidity20189,931,363Composition comprising probiotic bacteria for use in the treatment of immune disorders20189,925,224'Bacterial strains belonging to the genus bifidobacterium for use in the treatment of hypercholesterolaemia'20189,889,166'Treating low production of mucus in the gastrointestinal tract with S. thermophilus '20189,833,484Conjugated linoleic acid-producing strains of probiotic bacteria and use thereof for the preparation of a food, dietetic or pharmaceutical composition20179,498,503'Composition comprising probiotic bacteria for use in the treatment of immune disorders'20169,492,377'Effervescent composition in solid form for use in vaginal applications for the treatment of vaginal infections'20169,233,130'Probiotic bacteria based composition and use thereof in the prevention and/or treatment of respiratory pathologies and/or infections and in the improvement of the intestinal functionality'20169,185,927'Bacteriocin-producing Lactobacillus pentosus and the use thereof in food and pharmaceutical compositions'20158,734,783'Composition comprising probiotic bacteria for use in the treatment of immune disorders'20148,168,171'Folic acid producing bifidobacterium bacterial strains, formulations and use thereof'2012Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2012–2021Patents assigned to PROBIOTICAL SPA (17)· patent assignee history
2012–2021Patents assigned to MOGNA GIOVANNI (13)· patent assignee history
2012–2021Patents assigned to STROZZI GIAN PAOLO (10)· patent assignee history
2012–2021Based in Novara, IT· patent location history
2014–2021Patents assigned to MOGNA LUCA (6)· patent assignee history
2018–2020Patents assigned to PROBIOTICAL NORTH AMERICA INC (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| PROBIOTICAL SPA | 17 | 2012–2021 |
| MOGNA GIOVANNIself | 13 | 2012–2021 |
| STROZZI GIAN PAOLO | 10 | 2012–2021 |
| MOGNA LUCA | 6 | 2014–2021 |
| PROBIOTICAL NORTH AMERICA INC | 3 | 2018–2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| Novara, IT | 27 | 2012–2021 |